As of 2026-09-26, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (73.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.96 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -1019.4%.
The range of the Relative Valuation is (77.34) - (70.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.5x - 34.7x | 33.8x |
| Forward P/E multiples | 28.0x - 30.3x | 29.6x |
| Fair Price | (77.34) - (70.04) | (73.18) |
| Upside | -1071.6% - -980.0% | -1019.4% |
| Date | P/E |
| 2026-09-24 | -3.47 |
| 2026-09-23 | -3.49 |
| 2026-09-22 | -3.43 |
| 2026-09-21 | -3.47 |
| 2026-09-18 | -3.44 |
| 2026-09-17 | -3.48 |
| 2026-09-16 | -3.45 |
| 2026-09-15 | -3.47 |
| 2026-09-14 | -3.50 |
| 2026-09-11 | -3.48 |
| 2026-09-10 | -3.53 |
| 2026-09-09 | -3.44 |
| 2026-09-08 | -3.44 |
| 2026-09-04 | -3.47 |
| 2026-09-03 | -3.47 |
| 2026-09-02 | -3.55 |
| 2026-09-01 | -3.48 |
| 2026-08-31 | -3.51 |
| 2026-08-28 | -3.43 |
| 2026-08-27 | -3.42 |
| 2026-08-26 | -3.31 |
| 2026-08-25 | -3.28 |
| 2026-08-24 | -3.27 |
| 2026-08-21 | -3.24 |
| 2026-08-20 | -3.27 |
| 2026-08-19 | -3.07 |
| 2026-08-18 | -3.02 |
| 2026-08-17 | -2.82 |
| 2026-08-14 | -2.88 |
| 2026-08-13 | -2.89 |
| 2026-08-12 | -2.67 |
| 2026-08-11 | -2.66 |
| 2026-08-10 | -2.77 |
| 2026-08-07 | -2.80 |
| 2026-08-06 | -2.68 |
| 2026-08-05 | -2.76 |
| 2026-08-04 | -2.73 |
| 2026-08-03 | -2.73 |
| 2026-07-31 | -2.64 |
| 2026-07-30 | -2.64 |
| 2026-07-29 | -2.65 |
| 2026-07-28 | -2.56 |
| 2026-07-27 | -2.59 |
| 2026-07-24 | -2.60 |
| 2026-07-23 | -2.68 |
| 2026-07-22 | -2.66 |
| 2026-07-21 | -2.62 |
| 2026-07-20 | -2.65 |
| 2026-07-17 | -2.70 |
| 2026-07-16 | -2.58 |